NASDAQ: CRMDCormedix Inc Stock Ownership - Who owns Cormedix?
Insider buying vs selling
Have Cormedix Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joseph Todisco | Chief Executive Officer | 2024-05-10 | 26,982 | $5.17 | $139.50kSell |
| Joseph Todisco | Chief Executive Officer | 2024-03-13 | 13,561 | $3.74 | $50.72kBuy |
| Matthew T. David | Chief Financial Officer | 2024-01-12 | 5,216 | $3.47 | $18.10kSell |
| Elizabeth Massonhurlburt | EVP Head of Clinical Ops. | 2024-01-12 | 4,603 | $3.47 | $15.97kSell |
| Erin Mistry | Chief Commercial Officer | 2024-01-12 | 4,389 | $3.47 | $15.23kSell |
| Joseph Todisco | Chief Executive Officer | 2024-01-12 | 13,781 | $3.47 | $47.82kSell |
| Alan W. Dunton | Director | 2023-12-15 | 3,000 | $3.30 | $9.90kBuy |
| Alan W. Dunton | Director | 2023-12-14 | 3,000 | $3.45 | $10.35kBuy |
| Erin Mistry | Chief Commercial Officer | 2023-11-17 | 1,000 | $4.00 | $4.00kBuy |
| Steven W. Lefkowitz | Director | 2023-11-16 | 15,000 | $2.25 | $33.75kBuy |
CRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CRMD insiders and whales buy or sell their stock.
CRMD Shareholders
What type of owners hold Cormedix Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 6.36% | 3,553,474 | $25.09M | Institution |
| Vanguard Group Inc | 5.20% | 2,902,530 | $20.49M | Institution |
| Gary A. Gelbfish | 4.90% | 2,739,743 | $19.34M | Insider |
| Elliott Investment Management LP | 2.78% | 1,550,523 | $10.95M | Institution |
| Nomura Holdings Inc | 2.55% | 1,422,226 | $10.04M | Institution |
| Geode Capital Management LLC | 2.28% | 1,271,293 | $8.98M | Institution |
| State Street Corp | 2.18% | 1,215,552 | $8.58M | Institution |
| Pharmabio Development Inc | 1.39% | 778,563 | $5.50M | Insider |
| Randy Milby | 1.07% | 599,512 | $4.23M | Insider |
| Millennium Management LLC | 0.80% | 446,752 | $3.15M | Institution |
CRMD vs Biotech Stocks
Cormedix Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.